Balancing access and evaluation in the approval of new cancer drugs. Academic Article uri icon

Overview

publication date

  • June 8, 2011

Research

keywords

  • Antineoplastic Agents
  • Drug Approval
  • Randomized Controlled Trials as Topic
  • United States Food and Drug Administration

Identity

Scopus Document Identifier

  • 79958047618

Digital Object Identifier (DOI)

  • 10.1001/jama.2011.784

PubMed ID

  • 21642688

Additional Document Info

volume

  • 305

issue

  • 22